Key Points
-
Human natural killer (NK) cells interact with dendritic cells (DCs) in inflamed peripheral tissues.
-
NK cells induce DC maturation, but they also have cytolytic activity against immature DCs. So, NK cells regulate the progression of DC maturation by selecting the most appropriate antigen-presenting cells to undergo migration to secondary lymphoid compartments.
-
The cell-surface NK-cell receptor that is responsible for DC recognition and killing is the NKp30 molecule, a member of the natural cytotoxicity receptor (NCR) family.
-
In turn, DCs, which release interleukin-12 (IL-12) and IL-15 after antigen uptake, induce NK-cell activation. So, DCs can regulate NK-cell proliferation and lymphokine release in response to pathogens or tumours.
-
NK cells that express CC-chemokine receptor 7 (CCR7) migrate to secondary lymphoid compartments, where they exert quality control (editing) of mature DCs.
-
In patients with acute myeloid leukaemia (AML) who have received a bone-marrow transplant, alloreactive NK cells, derived from killer-cell immunoglobulin-like receptor (KIR)-mismatched donors, can kill leukaemic cells (graft-versus-leukaemia effect) and can prevent graft-versus-host reactions by killing DCs of the patient.
Abstract
Natural killer (NK) cells and dendritic cells (DCs) are two types of specialized cell of the innate immune system, the reciprocal interaction of which results in a potent, activating cross-talk. For example, DCs can prime resting NK cells, which, in turn, after activation, might induce DC maturation. However, NK cells negatively regulate the function of DCs also by killing immature DCs in peripheral tissues. Moreover, a subset of NK cells, after migration to secondary lymphoid tissues, might have a role in the editing of mature DCs based on the selective killing of mature DCs that do not express optimal surface densities of MHC class I molecules. So, cognate interactions between NK cells and DCs provide a coordinated mechanism that is involved not only in the regulation of innate immunity, but also in the promotion of appropriate downstream adaptive responses for defence against pathogens.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cooper, M. A., Fehniger, T. A. & Caligiuri, M. A. The biology of human natural killer-cell subsets. Trends Immunol. 22, 633–640 (2001).
Robertson, M. J. Role of chemokines in the biology of natural killer cells. J. Leukocyte Biol. 71, 173–183 (2002).
Moretta, A. et al. Receptors for HLA-class I molecules in human natural killer cells. Annu. Rev. Immunol. 14, 619–648 (1996).
Long, E. O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17, 875–904 (1999). References 3 and 4 focus on the various inhibitory natural killer (NK)-cell receptors that are specific for MHC class I molecules. These receptors allow NK cells to discriminate between immature and mature dendritic cells (DCs).
Garrido, F. et al. Implications for immunosurveillance of altered HLA-class I phenotypes in human tumors. Immunol. Today 18, 89–95 (1997).
Karre, K., Ljunggren, H. G., Piontek, G. & Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675–678 (1986).
Lopez-Botet, M., Llano, M. & Ortega, M. Human cytomegalovirus and natural killer-mediated survellance of HLA class I expression: a paradigm of host–pathogen adaptation. Immunol. Rev. 181, 193–202 (2001).
Vilches, C. & Parham, P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20, 217–251 (2002).
Wilson, M. J. et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl Acad. Sci. USA 97, 4778–4784 (2000).
Uhrberg, M. et al. Human diversity in killer-cell inhibitory receptor genes. Immunity 7, 753–760 (1997).
Moretta, A. et al. Identification of four subsets of human CD3−CD16+ NK cells by the expression of clonally distributed functional surface molecules. Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J. Exp. Med. 172, 1589–1598 (1990).
Moretta, A. et al. p58 molecules as putative receptors for MHC class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 178, 597–604 (1993).
Wagtmann, N. et al. Molecular clones of the p58 NK-cell receptor reveal immunoglobulin related molecules with diversity in both the extra- and intracellular domains. Immunity 2, 439–449 (1995).
Colonna, M. & Samaridis, J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268, 405–408 (1995).
D'Andrea, A. et al. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J. Immunol. 155, 2306–2310 (1995).
Gumperz, J. E., Litwin, V., Phillips, J. H., Lanier, L. L. & Parham, P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181, 1133–1144 (1995).
Vitale, M. et al. Physical and functional independency of p70 and p58 NK-cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK-cell clones. Proc. Natl Acad. Sci. USA 93, 1453–1457 (1996).
Valiante, N. M. et al. Functionally and structurally distinct NK-cell receptors in the peripheral blood of two human donors. Immunity 7, 739–751 (1997).
Moretta, A. et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19, 197–223 (2001).
Diefenbach, A. & Raulet, D. H. Strategies for target-cell recognition by natural killer cells. Immunol. Rev. 181, 170–184 (2001).
Cerwenka, A. & Lanier, L. L. Ligands for natural-killer-cell receptors: redundancy or specificity. Immunol. Rev. 181, 158–169 (2001).
Cosman, D. et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123–133 (2001). References 19–22 focus on the structure, function and ligand specificity of activating NK-cell receptors, including the various NCR, NKG2D and 2B4 molecules. At least one of these receptors (NKp30) seems to be involved directly in the recognition of DCs by human NK cells.
Costello, R. et al. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99, 3661–3667 (2002).
Steinman, R. M. & Cohn, Z. A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137, 1142–1162 (1973).
Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245–252 (1998).
Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767–811 (2000).
Randolph, G. J., Beaulieu, S., Lebecque, S., Steinman, R. M. & Muller, W. A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282, 480–483 (1998).
Sallusto, F. & Lanzavecchia, A. Mobilizing dendritic cells for tolerance, priming and chronic inflammation. J. Exp. Med. 189, 611–614 (1999).
Sallusto, F., Cella, M., Danieli, C. & Lanzavecchia, A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389–400 (1995).
De Baey, A. & Lanzavecchia, A. The role of aquaporins in dendritic-cell macropinocytosis. J. Exp. Med. 191, 743–747 (2000).
Reis e Sousa, C. Dendritic cells as sensors of infection. Immunity 14, 495–498 (2001).
Cella, M. et al. Maturation, activation and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189, 821–829 (1999).
Cella, M., Engering, A., Pinet, V., Pieters, J. & Lanzavecchia, A. Inflammatoy stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782–787 (1997).
Saeki, H., Moore, A. M., Brown, M. J. & Hwang, S. T. Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 162, 2472–2475 (1999).
Sallusto, F. et al. Distinct patterns and kinetics of chemokine production regulate dendritic-cell function. Eur. J. Immunol. 29, 1617–1625 (1999).
Sallusto, F., Mackay, C. R. & Lanzavecchia, A. The role of chemokine receptors in primary, effector and memory immune responses. Annu. Rev. Immunol. 18, 593–620 (2000).
Montoya, M. et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. Blood 99, 3263–3271 (2002).
Kalinski, P., Hilkens, C. M., Weirenga, E. A. & Kapsenberg, M. L. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20, 561–567 (1999).
Fernandez, N. et al. Dendritic cells directly trigger NK-cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nature Med. 5, 405–411 (1999). This is a pioneering study describing the existence of reciprocal control during NK-cell–DC interactions in the mouse system.
Ferlazzo, G. et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195, 343–351 (2002).
Piccioli, D., Sbrana, S., Melandri, E. & Valiante, N. M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195, 335–341 (2002).
Gerosa, F. et al. Reciprocal activating interaction between NK cells and dendritic cells. J. Exp. Med. 195, 327–333 (2002). References 40–42 address, for the first time, the issue of bi-directional cross-talk between NK cells and DCs in humans. It is shown that NK cells can kill DCs through NKp30, that NK cells proliferate in the presence of DCs and that NK cells can promote DC maturation.
Wilson, J. L. et al. Targeting of human dendritic cells by autologous NK cells. J. Immunol. 163, 6365–6370 (1999).
Spaggiari, G. M. et al. NK-cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur. J. Immunol. 31, 1656–1665 (2001).
Carbone, E. et al. Recognition of autologous dendritic cells by human NK cells. Eur. J. Immunol. 29, 4022–4029 (1999).
Zitvogel, L. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J. Exp. Med. 195, 9–14 (2002).
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. & Salazar-Mather, T. P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189–220 (1999). An authoritative review of the NK-cell response to various pathogens in vivo . Also, the migration of NK cells in response to innate cytokines is discussed.
Godiska, R. et al. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells and natural killer cells. J. Exp. Med. 185, 1595–1604 (1997).
Yoneda, O. et al. Fractalkine-mediated endothelial-cell injury by NK cells. J. Immunol. 164, 4055–4062 (2000).
Campbell, J. J. et al. Unique subpopulations of CD56+ NK and NKT peripheral-blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol. 166, 6477–6482 (2001). A complete analysis of chemokine-receptor expression by human NK-cell subsets.
Gerszten, R. E. et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398, 718–723 (1999).
Inngjerdingen, M., Damaj, B., Azzam, A. & Maghazachi, A. Expression and regulation of chemokine receptors in human natural killer cells. Blood 97, 367–375 (2001).
Imai, T. et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91, 521–530 (1997).
Yu, Y. et al. Enhancement of human cord-blood CD34+ cell-derived NK-cell cytotoxicity by DC. J. Immunol. 166, 1590–1600 (2001).
Nishioka, Y., Nishimura, N., Suzuki, Y. & Sone, S. Human derived monocyte-and CD83+ blood DC enhance NK-cell-mediated cytotoxicity. Eur. J. Immunol. 31, 2633–2641 (2001).
Granucci, F. et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nature Immunol. 2, 882–888 (2001).
Mattei, F., Schiavoni, G., Belardelli, F. & Tough, D. F. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic-cell activation. J. Immunol. 167, 1179–1187 (2001).
Iyoda, T. et al. The CD8+ dendritic-cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195, 1289–1302 (2002). This study provides direct evidence of the cooperation between NK cells and DCs during the process of endocytosis of dying cells.
Sauter, B. et al. Consequences of cell death. Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423–434 (2000).
Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: endogenous activators of dendritic cells. Nature Med. 5, 1249–1255 (1999).
Basu, S., Binder, R., Suto, R., Anderson, K. & Srivastava, P. Necrotic but not apoptotic cell death releases heat-shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int. Immunol. 12, 1539–1546 (2000).
Somersan, S. et al. Primary tumor tissue lysates are enriched in heat-shock proteins and induce the maturation of human dendritic cells. J. Immunol. 167, 4844–4852 (2001).
Albert, M. L., Sauter, B. & Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86–89 (1998).
Subklewe, M., Paludan, C., Tsang, M. L., Steinman, R. M. & Münz, C. Dendritic cells cross-present latency gene products from Epstein–Barr virus-transformed B cells and expand tumor-reactive CD8+ killer T cells. J. Exp. Med. 193, 405–412 (2001).
Albert, M. L. et al. Immature dendritic cells phagocytose apoptitic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188, 1359–1368 (1998).
Gorelik, L. & Flavell, R. A. Transforming growth factor-β in T-cell biology. Nature Rev. Immunol. 2, 46–53 (2002).
Ferlazzo, G., Semino, C. & Melioli, G. HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol. Lett. 76, 37–41 (2001).
Forster, R. et al. CCR7 coordinates the primary immune responses by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23–33 (1999).
Ruggieri, L. et al. Role of NK-cell alloreactivity in HLA-mismatched hematopoietic stem-cell transplantation. Blood 94, 333–339 (1999).
Ruggeri, L. et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097–2100 (2002). In this study, evidence is provided for the ability of KIR-mismatched alloreactive NK cells to prevent graft-versus-host disease by eliminating recipient antigen-presenting cells.
Kärre, K. A perfect mismatch. Science 295, 2029–2031 (2002).
Velardi, A., Ruggeri, L., Moretta, A. & Moretta, L. NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol. 23, 438–444 (2002).
Acknowledgements
I am grateful to A. Lanzavecchia and L. Moretta for helpful discussions and for critical reading of this manuscript. I also thank T. Baffi for secretarial assistance. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC), Istituto Superiore di Sanità (ISS), Capagnia San Paolo (Torino, Italy). Also, the financial support of Telethon-Italy is gratefully acknowledged.
Author information
Authors and Affiliations
Related links
Related links
DATABASES
Cancer.gov
LocusLink
Glossary
- KILLER-CELL IMMUNOGLOBULIN-LIKE RECEPTORS
-
(KIRs). These receptors, encoded on human chromosome 19, are expressed by NK-cell subsets and by a minor population of T cells. Inhibitory KIRs have locus and allele specificity for MHC class I molecules.
- CD94–NKG2A
-
A heterodimeric inhibitory receptor that is expressed by a main NK-cell subset and by certain T cells. Both CD94 and NKG2A molecules are encoded on human chromosome 12. This receptor recognizes HLA-E molecules that present signal-sequence peptides derived from most MHC class I alleles, except for HLA-BW4 alleles.
- NKp30
-
A member of the natural cytotoxicity receptor family that is involved in the activation of natural-killer-cell-mediated cytotoxicity. It is encoded on human chromosome 6 and its signalling depends on association with ζ and γ immunoreceptor tyrosine-based activation motif (ITAM)-containing polypeptides.
- MHC CLASS I POLYPEPTIDE-RELATED SEQUENCE A/B (MICA/MICB).
-
These are ligands for human NKG2D. They are closely related stress-inducible molecules that are encoded in the human MHC. These molecules are expressed by tumours of epithelial origin and certain melanomas.
- UL16-BINDING PROTEINS
-
(ULBPs). These are ligands for human NKG2D and for the human cytomegalovirus-encoded UL16 protein. They are glycosylphosphatidylinositol (GPI)-linked molecules that — unlike most members of the MHC class I family, which map to human chromosome 6p21 — map to chromosome 6q25. Three members of this family have been identified (ULBP1, ULBP2 and ULBP3).
- HEAT-SHOCK PROTEINS
-
(HSPs). Intracellular proteins that mediate many functions that are crucial for cellular survival. In eukaryotic cells, they are found in the cytosol, nucleus, mitochondria and endoplasmic reticulum. Under cellular stress, their level of expression is increased in many types of cell.
- SLC AND ELC
-
These are ligands for the CCR7 chemokine receptor. SLC (secondary lymphoid-tissue chemokine) is also known as CCL21, and ELC (Epstein–Barr virus-induced molecule 1 ligand chemokine) is also known as CCL19. Both are involved in lymphocyte recruitment through high endothelial venules to lymph nodes.
- ALLOREACTIVE NK CELLS
-
These cells can kill allogeneic haematopoietic targets. This is owing to the expression on their surface of killer-cell immunoglobulin-like receptors (KIRs) that cannot recognize the MHC class I alleles that are expressed by the allogeneic cells.
Rights and permissions
About this article
Cite this article
Moretta, A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2, 957–965 (2002). https://doi.org/10.1038/nri956
Issue Date:
DOI: https://doi.org/10.1038/nri956
This article is cited by
-
Transcriptome analysis of immune cells from Behçet’s syndrome patients: the importance of IL-17-producing cells and antigen-presenting cells in the pathogenesis of Behçet’s syndrome
Arthritis Research & Therapy (2022)
-
Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications
Stem Cell Research & Therapy (2022)
-
Innate immune responses in RNA viral infection
Frontiers of Medicine (2021)
-
Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma
International Journal of Oral Science (2020)
-
Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies
Stem Cell Research & Therapy (2019)